Clinical Trial Results:
Multicenter, randomized, open-label trial to evaluate the safety, tolerability and efficacy of two regimens of Everolimus plus Neoral, given according different blood target levels, in de novo renal transplant recipients Everest the upper target EVErolimus RandomizEd STudy
Summary
|
|
EudraCT number |
2005-000864-16 |
Trial protocol |
IT |
Global completion date |
24 Jul 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Aug 2016
|
First version publication date |
28 Aug 2016
|
Other versions |
|
Summary report(s) |
CRAD001AIT02.CTR.5Aug2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.